Antisense and siRNA technologies are proving invaluable tools in Molecular Biology and their applications in drug discovery and development are at the cutting edge of Pharmaceutical R&D. Allowing for the down- or upregulation of gene expression, interfering with protein function and provoking immune responses, such technologies represent powerful tools. In recent years this has represented an area of major technological advance, potentially fuelling rapid expansion of product pipelines.
Following SAE Media Group’s very successful event in February 2003, this Conference will aim to track the new developments of the last year, looking at new clinical trial results and approaches. The event will also endeavour to discuss the medicinal chemistry behind effective therapeutic design, drug delivery, manufacture and purification. As the industry broadens its knowledge of this exciting area, this event will discuss the strategies and practices in place and ideas for the future, to analyse the prospects and commercial potentials for antisense technologies.
A unique opportunity to learn from leading industry experts including:
· Dr Sudhir Agrawal, President & Chief Scientific Officer, Hybridon
· Dr Eric Marcusson, Associate Director, Functional Genomics, ISIS Pharmaceuticals
· Prof Patrick Iversen, Senior Vice President, Research & Development, AVI BioPharma
· Dr Jim Wright, Chief Executive Officer, Lorus Therapeutics
· Dr Barry Polisky, Senior Vice President, Research & Development, Sirna Therapeutics
· Dr William Marshall, Executive Vice President, Research, Development & Production, Dharmacon
Benefits of Attending:
· CLINICAL TRIALS UPDATE: Learn about the latest advances in antisense and siRNA technologies from the market leaders
· ANTISENSE TECHNOLOGY: Discover the principles and developments behind antisense technology
· INTELLECTUAL PROPERTY RIGHTS: Examine the latest in patent law issues affecting antisense and siRNA inventions
· MANUFACTURE & PURIFICATION: Understand the current methods
· KEY INDUSTRY PERSONNEL: Meet the leaders in the field and learn from their experience
“The schedule looks excellent…it’s brought together the key leaders in the field”
Dr Charles Wilson, Chief Technology Officer, Archemix